nodes	percent_of_prediction	percent_of_DWPC	metapath
Nepafenac—Nonsteroidal Anti-inflammatory Compounds—Acetylsalicylic acid—coronary artery disease	0.512	1	CiPCiCtD
Nepafenac—PTGS2—coronary artery disease	0.124	1	CbGaD
Nepafenac—Mefenamic acid—Acetylsalicylic acid—coronary artery disease	0.116	0.615	CrCrCtD
Nepafenac—Salsalate—Acetylsalicylic acid—coronary artery disease	0.0724	0.385	CrCrCtD
Nepafenac—PTGS2—Acetylsalicylic acid—coronary artery disease	0.0432	0.542	CbGbCtD
Nepafenac—PTGS1—Acetylsalicylic acid—coronary artery disease	0.0365	0.458	CbGbCtD
Nepafenac—Mebendazole—TUBA1A—coronary artery disease	0.000912	0.355	CrCbGaD
Nepafenac—Diclofenac—PLA2G2A—coronary artery disease	0.000337	0.131	CrCbGaD
Nepafenac—Carbamazepine—RALBP1—coronary artery disease	0.000219	0.0854	CrCbGaD
Nepafenac—Hypertension—Fenofibrate—coronary artery disease	0.00014	0.0022	CcSEcCtD
Nepafenac—Eye disorder—Trandolapril—coronary artery disease	0.00014	0.00219	CcSEcCtD
Nepafenac—Vision blurred—Simvastatin—coronary artery disease	0.00014	0.00219	CcSEcCtD
Nepafenac—Hypertension—Clopidogrel—coronary artery disease	0.000138	0.00216	CcSEcCtD
Nepafenac—Eye disorder—Telmisartan—coronary artery disease	0.000137	0.00215	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Fenofibrate—coronary artery disease	0.000137	0.00215	CcSEcCtD
Nepafenac—Sinusitis—Losartan—coronary artery disease	0.000136	0.00213	CcSEcCtD
Nepafenac—Angiopathy—Trandolapril—coronary artery disease	0.000136	0.00213	CcSEcCtD
Nepafenac—Dry mouth—Fenofibrate—coronary artery disease	0.000135	0.00212	CcSEcCtD
Nepafenac—Immune system disorder—Trandolapril—coronary artery disease	0.000135	0.00212	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Clopidogrel—coronary artery disease	0.000135	0.00212	CcSEcCtD
Nepafenac—Dizziness—Penbutolol—coronary artery disease	0.000135	0.00211	CcSEcCtD
Nepafenac—Hypertension—Ezetimibe—coronary artery disease	0.000134	0.00211	CcSEcCtD
Nepafenac—Angiopathy—Telmisartan—coronary artery disease	0.000133	0.00209	CcSEcCtD
Nepafenac—Immune system disorder—Telmisartan—coronary artery disease	0.000133	0.00208	CcSEcCtD
Nepafenac—Dry mouth—Lovastatin—coronary artery disease	0.000132	0.00207	CcSEcCtD
Nepafenac—Vision blurred—Valsartan—coronary artery disease	0.000132	0.00207	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—coronary artery disease	0.000132	0.00206	CcSEcCtD
Nepafenac—Vision blurred—Olmesartan—coronary artery disease	0.000131	0.00206	CcSEcCtD
Nepafenac—Nervous system disorder—Fenofibrate—coronary artery disease	0.00013	0.00204	CcSEcCtD
Nepafenac—Eye disorder—Perindopril—coronary artery disease	0.00013	0.00203	CcSEcCtD
Nepafenac—Dry mouth—Ezetimibe—coronary artery disease	0.00013	0.00203	CcSEcCtD
Nepafenac—Skin disorder—Fenofibrate—coronary artery disease	0.000129	0.00202	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Eplerenone—coronary artery disease	0.000129	0.00202	CcSEcCtD
Nepafenac—Vision blurred—Niacin—coronary artery disease	0.000128	0.00201	CcSEcCtD
Nepafenac—Nervous system disorder—Clopidogrel—coronary artery disease	0.000128	0.002	CcSEcCtD
Nepafenac—Headache—Penbutolol—coronary artery disease	0.000128	0.002	CcSEcCtD
Nepafenac—Skin disorder—Clopidogrel—coronary artery disease	0.000127	0.00198	CcSEcCtD
Nepafenac—Vision blurred—Pravastatin—coronary artery disease	0.000126	0.00198	CcSEcCtD
Nepafenac—Eye disorder—Furosemide—coronary artery disease	0.000126	0.00198	CcSEcCtD
Nepafenac—Angiopathy—Perindopril—coronary artery disease	0.000126	0.00197	CcSEcCtD
Nepafenac—Hypersensitivity—Ticagrelor—coronary artery disease	0.000125	0.00196	CcSEcCtD
Nepafenac—Nervous system disorder—Ezetimibe—coronary artery disease	0.000125	0.00195	CcSEcCtD
Nepafenac—Skin disorder—Ezetimibe—coronary artery disease	0.000123	0.00193	CcSEcCtD
Nepafenac—Pruritus—Gemfibrozil—coronary artery disease	0.000123	0.00193	CcSEcCtD
Nepafenac—Angiopathy—Furosemide—coronary artery disease	0.000122	0.00192	CcSEcCtD
Nepafenac—Vision blurred—Enalapril—coronary artery disease	0.000122	0.00192	CcSEcCtD
Nepafenac—Nervous system disorder—Eplerenone—coronary artery disease	0.000122	0.00191	CcSEcCtD
Nepafenac—Immune system disorder—Furosemide—coronary artery disease	0.000122	0.00191	CcSEcCtD
Nepafenac—Nausea—Penbutolol—coronary artery disease	0.000121	0.0019	CcSEcCtD
Nepafenac—Skin disorder—Eplerenone—coronary artery disease	0.000121	0.00189	CcSEcCtD
Nepafenac—Pruritus—Ticagrelor—coronary artery disease	0.00012	0.00188	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Valsartan—coronary artery disease	0.000118	0.00186	CcSEcCtD
Nepafenac—Angiopathy—Losartan—coronary artery disease	0.000118	0.00185	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Olmesartan—coronary artery disease	0.000118	0.00185	CcSEcCtD
Nepafenac—Vision blurred—Captopril—coronary artery disease	0.000117	0.00184	CcSEcCtD
Nepafenac—Dry mouth—Valsartan—coronary artery disease	0.000117	0.00183	CcSEcCtD
Nepafenac—Sinusitis—Ramipril—coronary artery disease	0.000117	0.00183	CcSEcCtD
Nepafenac—Hypertension—Pravastatin—coronary artery disease	0.000116	0.00182	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Niacin—coronary artery disease	0.000115	0.00181	CcSEcCtD
Nepafenac—Dizziness—Gemfibrozil—coronary artery disease	0.000115	0.0018	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Fenofibrate—coronary artery disease	0.000114	0.00179	CcSEcCtD
Nepafenac—Sinusitis—Timolol—coronary artery disease	0.000114	0.00179	CcSEcCtD
Nepafenac—Dry mouth—Niacin—coronary artery disease	0.000113	0.00178	CcSEcCtD
Nepafenac—Hypersensitivity—Rosuvastatin—coronary artery disease	0.000113	0.00176	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Clopidogrel—coronary artery disease	0.000113	0.00176	CcSEcCtD
Nepafenac—Dizziness—Ticagrelor—coronary artery disease	0.000112	0.00176	CcSEcCtD
Nepafenac—Nervous system disorder—Valsartan—coronary artery disease	0.000112	0.00176	CcSEcCtD
Nepafenac—Nervous system disorder—Olmesartan—coronary artery disease	0.000112	0.00175	CcSEcCtD
Nepafenac—Skin disorder—Valsartan—coronary artery disease	0.000111	0.00174	CcSEcCtD
Nepafenac—Vision blurred—Furosemide—coronary artery disease	0.000111	0.00174	CcSEcCtD
Nepafenac—Skin disorder—Olmesartan—coronary artery disease	0.000111	0.00173	CcSEcCtD
Nepafenac—Hypertension—Telmisartan—coronary artery disease	0.00011	0.00173	CcSEcCtD
Nepafenac—Vomiting—Gemfibrozil—coronary artery disease	0.00011	0.00173	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Trandolapril—coronary artery disease	0.00011	0.00173	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Ezetimibe—coronary artery disease	0.00011	0.00172	CcSEcCtD
Nepafenac—Hypersensitivity—Acetylsalicylic acid—coronary artery disease	0.000109	0.00171	CcSEcCtD
Nepafenac—Headache—Gemfibrozil—coronary artery disease	0.000109	0.00171	CcSEcCtD
Nepafenac—Dry mouth—Trandolapril—coronary artery disease	0.000108	0.0017	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Telmisartan—coronary artery disease	0.000108	0.0017	CcSEcCtD
Nepafenac—Pruritus—Rosuvastatin—coronary artery disease	0.000108	0.00169	CcSEcCtD
Nepafenac—Dry mouth—Enalapril—coronary artery disease	0.000108	0.00169	CcSEcCtD
Nepafenac—Skin disorder—Niacin—coronary artery disease	0.000108	0.00169	CcSEcCtD
Nepafenac—Vomiting—Ticagrelor—coronary artery disease	0.000108	0.00169	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Eplerenone—coronary artery disease	0.000107	0.00168	CcSEcCtD
Nepafenac—Vision blurred—Losartan—coronary artery disease	0.000107	0.00167	CcSEcCtD
Nepafenac—Dry mouth—Telmisartan—coronary artery disease	0.000107	0.00167	CcSEcCtD
Nepafenac—Headache—Ticagrelor—coronary artery disease	0.000106	0.00167	CcSEcCtD
Nepafenac—Sinusitis—Lisinopril—coronary artery disease	0.000106	0.00166	CcSEcCtD
Nepafenac—Pruritus—Acetylsalicylic acid—coronary artery disease	0.000105	0.00165	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Simvastatin—coronary artery disease	0.000105	0.00164	CcSEcCtD
Nepafenac—Hypertension—Perindopril—coronary artery disease	0.000104	0.00164	CcSEcCtD
Nepafenac—Nervous system disorder—Trandolapril—coronary artery disease	0.000104	0.00163	CcSEcCtD
Nepafenac—Dry mouth—Captopril—coronary artery disease	0.000104	0.00162	CcSEcCtD
Nepafenac—Skin disorder—Trandolapril—coronary artery disease	0.000103	0.00162	CcSEcCtD
Nepafenac—Nausea—Gemfibrozil—coronary artery disease	0.000103	0.00162	CcSEcCtD
Nepafenac—Nervous system disorder—Telmisartan—coronary artery disease	0.000102	0.00161	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Perindopril—coronary artery disease	0.000102	0.0016	CcSEcCtD
Nepafenac—Eye disorder—Timolol—coronary artery disease	0.000102	0.0016	CcSEcCtD
Nepafenac—Skin disorder—Telmisartan—coronary artery disease	0.000101	0.00159	CcSEcCtD
Nepafenac—Dizziness—Rosuvastatin—coronary artery disease	0.000101	0.00158	CcSEcCtD
Nepafenac—Immune system disorder—Ramipril—coronary artery disease	0.000101	0.00158	CcSEcCtD
Nepafenac—Nausea—Ticagrelor—coronary artery disease	0.000101	0.00158	CcSEcCtD
Nepafenac—Dry mouth—Perindopril—coronary artery disease	0.000101	0.00158	CcSEcCtD
Nepafenac—Diclofenac—CXCL8—coronary artery disease	0.0001	0.039	CrCbGaD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Furosemide—coronary artery disease	9.93e-05	0.00156	CcSEcCtD
Nepafenac—Angiopathy—Timolol—coronary artery disease	9.9e-05	0.00155	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Valsartan—coronary artery disease	9.87e-05	0.00155	CcSEcCtD
Nepafenac—Immune system disorder—Timolol—coronary artery disease	9.86e-05	0.00155	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Olmesartan—coronary artery disease	9.82e-05	0.00154	CcSEcCtD
Nepafenac—Dizziness—Acetylsalicylic acid—coronary artery disease	9.81e-05	0.00154	CcSEcCtD
Nepafenac—Dry mouth—Furosemide—coronary artery disease	9.78e-05	0.00153	CcSEcCtD
Nepafenac—Hypersensitivity—Fenofibrate—coronary artery disease	9.77e-05	0.00153	CcSEcCtD
Nepafenac—Nervous system disorder—Perindopril—coronary artery disease	9.67e-05	0.00152	CcSEcCtD
Nepafenac—Hypersensitivity—Clopidogrel—coronary artery disease	9.6e-05	0.00151	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Niacin—coronary artery disease	9.6e-05	0.00151	CcSEcCtD
Nepafenac—Skin disorder—Perindopril—coronary artery disease	9.58e-05	0.0015	CcSEcCtD
Nepafenac—Headache—Rosuvastatin—coronary artery disease	9.57e-05	0.0015	CcSEcCtD
Nepafenac—Hypersensitivity—Lovastatin—coronary artery disease	9.54e-05	0.0015	CcSEcCtD
Nepafenac—Vomiting—Acetylsalicylic acid—coronary artery disease	9.43e-05	0.00148	CcSEcCtD
Nepafenac—Dry mouth—Losartan—coronary artery disease	9.43e-05	0.00148	CcSEcCtD
Nepafenac—Nervous system disorder—Furosemide—coronary artery disease	9.4e-05	0.00147	CcSEcCtD
Nepafenac—Pruritus—Fenofibrate—coronary artery disease	9.38e-05	0.00147	CcSEcCtD
Nepafenac—Hypersensitivity—Ezetimibe—coronary artery disease	9.35e-05	0.00147	CcSEcCtD
Nepafenac—Skin disorder—Furosemide—coronary artery disease	9.31e-05	0.00146	CcSEcCtD
Nepafenac—Pruritus—Clopidogrel—coronary artery disease	9.22e-05	0.00145	CcSEcCtD
Nepafenac—Angiopathy—Lisinopril—coronary artery disease	9.18e-05	0.00144	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Trandolapril—coronary artery disease	9.18e-05	0.00144	CcSEcCtD
Nepafenac—Pruritus—Lovastatin—coronary artery disease	9.16e-05	0.00144	CcSEcCtD
Nepafenac—Nausea—Rosuvastatin—coronary artery disease	9.07e-05	0.00142	CcSEcCtD
Nepafenac—Nervous system disorder—Losartan—coronary artery disease	9.07e-05	0.00142	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Telmisartan—coronary artery disease	9.02e-05	0.00141	CcSEcCtD
Nepafenac—Pruritus—Ezetimibe—coronary artery disease	8.98e-05	0.00141	CcSEcCtD
Nepafenac—Vision blurred—Timolol—coronary artery disease	8.95e-05	0.0014	CcSEcCtD
Nepafenac—Hypersensitivity—Simvastatin—coronary artery disease	8.92e-05	0.0014	CcSEcCtD
Nepafenac—Ketoprofen—CXCL8—coronary artery disease	8.87e-05	0.0345	CrCbGaD
Nepafenac—Nausea—Acetylsalicylic acid—coronary artery disease	8.81e-05	0.00138	CcSEcCtD
Nepafenac—Pruritus—Eplerenone—coronary artery disease	8.79e-05	0.00138	CcSEcCtD
Nepafenac—Dizziness—Fenofibrate—coronary artery disease	8.77e-05	0.00137	CcSEcCtD
Nepafenac—Dizziness—Clopidogrel—coronary artery disease	8.62e-05	0.00135	CcSEcCtD
Nepafenac—Pruritus—Simvastatin—coronary artery disease	8.57e-05	0.00134	CcSEcCtD
Nepafenac—Dizziness—Lovastatin—coronary artery disease	8.56e-05	0.00134	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Perindopril—coronary artery disease	8.51e-05	0.00133	CcSEcCtD
Nepafenac—Vomiting—Fenofibrate—coronary artery disease	8.43e-05	0.00132	CcSEcCtD
Nepafenac—Hypersensitivity—Valsartan—coronary artery disease	8.42e-05	0.00132	CcSEcCtD
Nepafenac—Dizziness—Ezetimibe—coronary artery disease	8.4e-05	0.00132	CcSEcCtD
Nepafenac—Headache—Fenofibrate—coronary artery disease	8.3e-05	0.0013	CcSEcCtD
Nepafenac—Vision blurred—Lisinopril—coronary artery disease	8.3e-05	0.0013	CcSEcCtD
Nepafenac—Vomiting—Clopidogrel—coronary artery disease	8.29e-05	0.0013	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Furosemide—coronary artery disease	8.27e-05	0.0013	CcSEcCtD
Nepafenac—Ketorolac—PTGS2—coronary artery disease	8.24e-05	0.0321	CrCbGaD
Nepafenac—Vomiting—Lovastatin—coronary artery disease	8.23e-05	0.00129	CcSEcCtD
Nepafenac—Dizziness—Eplerenone—coronary artery disease	8.22e-05	0.00129	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	8.21e-05	0.00129	CcSEcCtD
Nepafenac—Hypertension—Timolol—coronary artery disease	8.2e-05	0.00129	CcSEcCtD
Nepafenac—Hypersensitivity—Niacin—coronary artery disease	8.19e-05	0.00128	CcSEcCtD
Nepafenac—Headache—Clopidogrel—coronary artery disease	8.16e-05	0.00128	CcSEcCtD
Nepafenac—Headache—Lovastatin—coronary artery disease	8.11e-05	0.00127	CcSEcCtD
Nepafenac—Pruritus—Valsartan—coronary artery disease	8.09e-05	0.00127	CcSEcCtD
Nepafenac—Dry mouth—Ramipril—coronary artery disease	8.09e-05	0.00127	CcSEcCtD
Nepafenac—Vomiting—Ezetimibe—coronary artery disease	8.07e-05	0.00127	CcSEcCtD
Nepafenac—Hypersensitivity—Pravastatin—coronary artery disease	8.06e-05	0.00126	CcSEcCtD
Nepafenac—Pruritus—Olmesartan—coronary artery disease	8.05e-05	0.00126	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	8.03e-05	0.00126	CcSEcCtD
Nepafenac—Dizziness—Simvastatin—coronary artery disease	8.01e-05	0.00126	CcSEcCtD
Nepafenac—Headache—Ezetimibe—coronary artery disease	7.95e-05	0.00125	CcSEcCtD
Nepafenac—Dry mouth—Timolol—coronary artery disease	7.91e-05	0.00124	CcSEcCtD
Nepafenac—Vomiting—Eplerenone—coronary artery disease	7.9e-05	0.00124	CcSEcCtD
Nepafenac—Bromfenac—PTGS2—coronary artery disease	7.9e-05	0.0307	CrCbGaD
Nepafenac—Nausea—Fenofibrate—coronary artery disease	7.87e-05	0.00123	CcSEcCtD
Nepafenac—Pruritus—Niacin—coronary artery disease	7.87e-05	0.00123	CcSEcCtD
Nepafenac—Hypersensitivity—Trandolapril—coronary artery disease	7.83e-05	0.00123	CcSEcCtD
Nepafenac—Hypersensitivity—Enalapril—coronary artery disease	7.8e-05	0.00122	CcSEcCtD
Nepafenac—Headache—Eplerenone—coronary artery disease	7.78e-05	0.00122	CcSEcCtD
Nepafenac—Nervous system disorder—Ramipril—coronary artery disease	7.78e-05	0.00122	CcSEcCtD
Nepafenac—Pruritus—Pravastatin—coronary artery disease	7.74e-05	0.00121	CcSEcCtD
Nepafenac—Nausea—Clopidogrel—coronary artery disease	7.74e-05	0.00121	CcSEcCtD
Nepafenac—Skin disorder—Ramipril—coronary artery disease	7.7e-05	0.00121	CcSEcCtD
Nepafenac—Vomiting—Simvastatin—coronary artery disease	7.7e-05	0.00121	CcSEcCtD
Nepafenac—Hypersensitivity—Telmisartan—coronary artery disease	7.69e-05	0.00121	CcSEcCtD
Nepafenac—Nausea—Lovastatin—coronary artery disease	7.69e-05	0.00121	CcSEcCtD
Nepafenac—Nervous system disorder—Timolol—coronary artery disease	7.6e-05	0.00119	CcSEcCtD
Nepafenac—Headache—Simvastatin—coronary artery disease	7.59e-05	0.00119	CcSEcCtD
Nepafenac—Dizziness—Valsartan—coronary artery disease	7.56e-05	0.00119	CcSEcCtD
Nepafenac—Nausea—Ezetimibe—coronary artery disease	7.54e-05	0.00118	CcSEcCtD
Nepafenac—Skin disorder—Timolol—coronary artery disease	7.53e-05	0.00118	CcSEcCtD
Nepafenac—Dizziness—Olmesartan—coronary artery disease	7.52e-05	0.00118	CcSEcCtD
Nepafenac—Pruritus—Trandolapril—coronary artery disease	7.52e-05	0.00118	CcSEcCtD
Nepafenac—Pruritus—Enalapril—coronary artery disease	7.49e-05	0.00117	CcSEcCtD
Nepafenac—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	7.45e-05	0.00117	CcSEcCtD
Nepafenac—Pruritus—Telmisartan—coronary artery disease	7.39e-05	0.00116	CcSEcCtD
Nepafenac—Nausea—Eplerenone—coronary artery disease	7.38e-05	0.00116	CcSEcCtD
Nepafenac—Dizziness—Niacin—coronary artery disease	7.35e-05	0.00115	CcSEcCtD
Nepafenac—Dry mouth—Lisinopril—coronary artery disease	7.34e-05	0.00115	CcSEcCtD
Nepafenac—Vomiting—Valsartan—coronary artery disease	7.27e-05	0.00114	CcSEcCtD
Nepafenac—Dizziness—Pravastatin—coronary artery disease	7.24e-05	0.00114	CcSEcCtD
Nepafenac—Vomiting—Olmesartan—coronary artery disease	7.24e-05	0.00113	CcSEcCtD
Nepafenac—Nausea—Simvastatin—coronary artery disease	7.19e-05	0.00113	CcSEcCtD
Nepafenac—Pruritus—Captopril—coronary artery disease	7.18e-05	0.00113	CcSEcCtD
Nepafenac—Headache—Valsartan—coronary artery disease	7.16e-05	0.00112	CcSEcCtD
Nepafenac—Headache—Olmesartan—coronary artery disease	7.13e-05	0.00112	CcSEcCtD
Nepafenac—Vomiting—Niacin—coronary artery disease	7.07e-05	0.00111	CcSEcCtD
Nepafenac—Hypersensitivity—Furosemide—coronary artery disease	7.06e-05	0.00111	CcSEcCtD
Nepafenac—Dizziness—Trandolapril—coronary artery disease	7.03e-05	0.0011	CcSEcCtD
Nepafenac—Dizziness—Enalapril—coronary artery disease	7e-05	0.0011	CcSEcCtD
Nepafenac—Skin disorder—Lisinopril—coronary artery disease	6.99e-05	0.0011	CcSEcCtD
Nepafenac—Pruritus—Perindopril—coronary artery disease	6.98e-05	0.00109	CcSEcCtD
Nepafenac—Headache—Niacin—coronary artery disease	6.96e-05	0.00109	CcSEcCtD
Nepafenac—Vomiting—Pravastatin—coronary artery disease	6.96e-05	0.00109	CcSEcCtD
Nepafenac—Dizziness—Telmisartan—coronary artery disease	6.91e-05	0.00108	CcSEcCtD
Nepafenac—Headache—Pravastatin—coronary artery disease	6.86e-05	0.00108	CcSEcCtD
Nepafenac—Gastrointestinal disorder—Ramipril—coronary artery disease	6.85e-05	0.00107	CcSEcCtD
Nepafenac—Hypersensitivity—Losartan—coronary artery disease	6.81e-05	0.00107	CcSEcCtD
Nepafenac—Nausea—Valsartan—coronary artery disease	6.79e-05	0.00106	CcSEcCtD
Nepafenac—Pruritus—Furosemide—coronary artery disease	6.78e-05	0.00106	CcSEcCtD
Nepafenac—Nausea—Olmesartan—coronary artery disease	6.76e-05	0.00106	CcSEcCtD
Nepafenac—Vomiting—Trandolapril—coronary artery disease	6.76e-05	0.00106	CcSEcCtD
Nepafenac—Vomiting—Enalapril—coronary artery disease	6.73e-05	0.00106	CcSEcCtD
Nepafenac—Dizziness—Captopril—coronary artery disease	6.71e-05	0.00105	CcSEcCtD
Nepafenac—Tiaprofenic acid—PTGS2—coronary artery disease	6.71e-05	0.0261	CrCbGaD
Nepafenac—Gastrointestinal disorder—Timolol—coronary artery disease	6.69e-05	0.00105	CcSEcCtD
Nepafenac—Headache—Trandolapril—coronary artery disease	6.66e-05	0.00104	CcSEcCtD
Nepafenac—Vomiting—Telmisartan—coronary artery disease	6.64e-05	0.00104	CcSEcCtD
Nepafenac—Headache—Enalapril—coronary artery disease	6.63e-05	0.00104	CcSEcCtD
Nepafenac—Nausea—Niacin—coronary artery disease	6.6e-05	0.00104	CcSEcCtD
Nepafenac—Pruritus—Losartan—coronary artery disease	6.54e-05	0.00103	CcSEcCtD
Nepafenac—Headache—Telmisartan—coronary artery disease	6.54e-05	0.00103	CcSEcCtD
Nepafenac—Dizziness—Perindopril—coronary artery disease	6.52e-05	0.00102	CcSEcCtD
Nepafenac—Nausea—Pravastatin—coronary artery disease	6.5e-05	0.00102	CcSEcCtD
Nepafenac—Vomiting—Captopril—coronary artery disease	6.46e-05	0.00101	CcSEcCtD
Nepafenac—Headache—Captopril—coronary artery disease	6.36e-05	0.000998	CcSEcCtD
Nepafenac—Dizziness—Furosemide—coronary artery disease	6.34e-05	0.000994	CcSEcCtD
Nepafenac—Nausea—Trandolapril—coronary artery disease	6.31e-05	0.00099	CcSEcCtD
Nepafenac—Nausea—Enalapril—coronary artery disease	6.29e-05	0.000986	CcSEcCtD
Nepafenac—Vomiting—Perindopril—coronary artery disease	6.27e-05	0.000983	CcSEcCtD
Nepafenac—Magnesium salicylate—PTGS2—coronary artery disease	6.24e-05	0.0243	CrCbGaD
Nepafenac—Gastrointestinal disorder—Lisinopril—coronary artery disease	6.21e-05	0.000974	CcSEcCtD
Nepafenac—Nausea—Telmisartan—coronary artery disease	6.2e-05	0.000973	CcSEcCtD
Nepafenac—Headache—Perindopril—coronary artery disease	6.18e-05	0.000969	CcSEcCtD
Nepafenac—Dizziness—Losartan—coronary artery disease	6.12e-05	0.000959	CcSEcCtD
Nepafenac—Fenbufen—PTGS2—coronary artery disease	6.11e-05	0.0238	CrCbGaD
Nepafenac—Vomiting—Furosemide—coronary artery disease	6.09e-05	0.000956	CcSEcCtD
Nepafenac—Nausea—Captopril—coronary artery disease	6.03e-05	0.000946	CcSEcCtD
Nepafenac—Headache—Furosemide—coronary artery disease	6e-05	0.000942	CcSEcCtD
Nepafenac—Oxcarbazepine—CYP2C19—coronary artery disease	5.91e-05	0.023	CrCbGaD
Nepafenac—Vomiting—Losartan—coronary artery disease	5.88e-05	0.000922	CcSEcCtD
Nepafenac—Nausea—Perindopril—coronary artery disease	5.86e-05	0.000918	CcSEcCtD
Nepafenac—Hypersensitivity—Ramipril—coronary artery disease	5.84e-05	0.000916	CcSEcCtD
Nepafenac—Headache—Losartan—coronary artery disease	5.79e-05	0.000908	CcSEcCtD
Nepafenac—Hypersensitivity—Timolol—coronary artery disease	5.71e-05	0.000896	CcSEcCtD
Nepafenac—Nausea—Furosemide—coronary artery disease	5.69e-05	0.000893	CcSEcCtD
Nepafenac—Pruritus—Ramipril—coronary artery disease	5.61e-05	0.00088	CcSEcCtD
Nepafenac—Magnesium salicylate—ALB—coronary artery disease	5.56e-05	0.0216	CrCbGaD
Nepafenac—Nausea—Losartan—coronary artery disease	5.49e-05	0.000861	CcSEcCtD
Nepafenac—Pruritus—Timolol—coronary artery disease	5.48e-05	0.00086	CcSEcCtD
Nepafenac—Salsalate—PTGS2—coronary artery disease	5.31e-05	0.0207	CrCbGaD
Nepafenac—Hypersensitivity—Lisinopril—coronary artery disease	5.3e-05	0.000831	CcSEcCtD
Nepafenac—Dizziness—Ramipril—coronary artery disease	5.24e-05	0.000822	CcSEcCtD
Nepafenac—Dizziness—Timolol—coronary artery disease	5.13e-05	0.000804	CcSEcCtD
Nepafenac—Pruritus—Lisinopril—coronary artery disease	5.09e-05	0.000798	CcSEcCtD
Nepafenac—Vomiting—Ramipril—coronary artery disease	5.04e-05	0.000791	CcSEcCtD
Nepafenac—Headache—Ramipril—coronary artery disease	4.97e-05	0.000779	CcSEcCtD
Nepafenac—Vomiting—Timolol—coronary artery disease	4.93e-05	0.000773	CcSEcCtD
Nepafenac—Headache—Timolol—coronary artery disease	4.86e-05	0.000761	CcSEcCtD
Nepafenac—Dizziness—Lisinopril—coronary artery disease	4.76e-05	0.000746	CcSEcCtD
Nepafenac—Nausea—Ramipril—coronary artery disease	4.71e-05	0.000739	CcSEcCtD
Nepafenac—Diclofenac—CYP2C19—coronary artery disease	4.69e-05	0.0183	CrCbGaD
Nepafenac—Nausea—Timolol—coronary artery disease	4.6e-05	0.000722	CcSEcCtD
Nepafenac—Vomiting—Lisinopril—coronary artery disease	4.57e-05	0.000717	CcSEcCtD
Nepafenac—Headache—Lisinopril—coronary artery disease	4.51e-05	0.000706	CcSEcCtD
Nepafenac—Modafinil—CYP2C19—coronary artery disease	4.41e-05	0.0172	CrCbGaD
Nepafenac—Fenoprofen—PTGS2—coronary artery disease	4.38e-05	0.0171	CrCbGaD
Nepafenac—Nausea—Lisinopril—coronary artery disease	4.27e-05	0.00067	CcSEcCtD
Nepafenac—Mefenamic acid—PTGS2—coronary artery disease	4.07e-05	0.0158	CrCbGaD
Nepafenac—Carbamazepine—CYP2C19—coronary artery disease	4.03e-05	0.0157	CrCbGaD
Nepafenac—Fenoprofen—ALB—coronary artery disease	3.91e-05	0.0152	CrCbGaD
Nepafenac—Oxcarbazepine—ALB—coronary artery disease	3.28e-05	0.0128	CrCbGaD
Nepafenac—Diclofenac—PTGS2—coronary artery disease	2.92e-05	0.0114	CrCbGaD
Nepafenac—Diclofenac—ALB—coronary artery disease	2.6e-05	0.0101	CrCbGaD
Nepafenac—Ketoprofen—PTGS2—coronary artery disease	2.59e-05	0.0101	CrCbGaD
Nepafenac—Ketoprofen—ALB—coronary artery disease	2.31e-05	0.00898	CrCbGaD
Nepafenac—PTGS2—Disease—HK2—coronary artery disease	1.61e-05	0.000542	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CTGF—coronary artery disease	1.6e-05	0.00054	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CPT1B—coronary artery disease	1.59e-05	0.000538	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LCAT—coronary artery disease	1.59e-05	0.000538	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—MAPK1—coronary artery disease	1.59e-05	0.000537	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—HMGCR—coronary artery disease	1.59e-05	0.000535	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CKB—coronary artery disease	1.58e-05	0.000534	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PYGB—coronary artery disease	1.58e-05	0.000534	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOA4—coronary artery disease	1.56e-05	0.000528	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—IL6—coronary artery disease	1.55e-05	0.000522	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FZD2—coronary artery disease	1.54e-05	0.00052	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	1.54e-05	0.000518	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TNF—coronary artery disease	1.51e-05	0.000511	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GCLM—coronary artery disease	1.51e-05	0.00051	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PDHA1—coronary artery disease	1.51e-05	0.00051	CbGpPWpGaD
Nepafenac—PTGS2—Disease—RPL17—coronary artery disease	1.51e-05	0.00051	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SFRP2—coronary artery disease	1.51e-05	0.00051	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PFKFB3—coronary artery disease	1.49e-05	0.000502	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PLIN1—coronary artery disease	1.49e-05	0.000502	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—DLAT—coronary artery disease	1.49e-05	0.000502	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—COX5B—coronary artery disease	1.49e-05	0.000502	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GSTM2—coronary artery disease	1.49e-05	0.000502	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APOA4—coronary artery disease	1.48e-05	0.0005	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	1.46e-05	0.000494	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—TXNRD1—coronary artery disease	1.46e-05	0.000494	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP11B2—coronary artery disease	1.46e-05	0.000494	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SLC22A3—coronary artery disease	1.44e-05	0.000486	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ARNTL—coronary artery disease	1.42e-05	0.000479	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HADH—coronary artery disease	1.42e-05	0.000479	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—coronary artery disease	1.42e-05	0.000478	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—coronary artery disease	1.41e-05	0.000477	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SULT1E1—coronary artery disease	1.41e-05	0.000476	CbGpPWpGaD
Nepafenac—PTGS2—Disease—DVL1—coronary artery disease	1.41e-05	0.000475	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	1.4e-05	0.000472	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—coronary artery disease	1.38e-05	0.000465	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—GGT1—coronary artery disease	1.37e-05	0.000462	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	1.36e-05	0.00046	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PLA2G2A—coronary artery disease	1.35e-05	0.000454	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GPX2—coronary artery disease	1.35e-05	0.000454	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOA2—coronary artery disease	1.35e-05	0.000454	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CANX—coronary artery disease	1.35e-05	0.000454	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—AKR1B1—coronary artery disease	1.35e-05	0.000454	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HK2—coronary artery disease	1.35e-05	0.000454	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ABCG5—coronary artery disease	1.33e-05	0.000449	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GPX4—coronary artery disease	1.33e-05	0.000449	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SULT1A1—coronary artery disease	1.33e-05	0.000449	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HK1—coronary artery disease	1.33e-05	0.000449	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	1.33e-05	0.000448	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HADHA—coronary artery disease	1.31e-05	0.000443	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TLE4—coronary artery disease	1.31e-05	0.000442	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GSTA1—coronary artery disease	1.3e-05	0.000438	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC27A1—coronary artery disease	1.29e-05	0.000435	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LPA—coronary artery disease	1.28e-05	0.000433	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APOA2—coronary artery disease	1.28e-05	0.000431	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CPT1B—coronary artery disease	1.26e-05	0.000427	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LCAT—coronary artery disease	1.26e-05	0.000427	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HK1—coronary artery disease	1.26e-05	0.000425	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PLCB3—coronary artery disease	1.24e-05	0.00042	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOA4—coronary artery disease	1.24e-05	0.000419	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOA5—coronary artery disease	1.23e-05	0.000415	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL6—coronary artery disease	1.22e-05	0.000412	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PPARGC1A—coronary artery disease	1.22e-05	0.000411	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—P4HB—coronary artery disease	1.21e-05	0.000407	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—coronary artery disease	1.2e-05	0.000406	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PDHA1—coronary artery disease	1.2e-05	0.000405	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GCLM—coronary artery disease	1.2e-05	0.000405	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	1.2e-05	0.000404	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NR4A1—coronary artery disease	1.19e-05	0.000402	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PLA2G1B—coronary artery disease	1.19e-05	0.0004	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HDAC9—coronary artery disease	1.18e-05	0.000398	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	1.17e-05	0.000395	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—APOB—coronary artery disease	1.16e-05	0.000392	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP11B2—coronary artery disease	1.16e-05	0.000392	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—TXNRD1—coronary artery disease	1.16e-05	0.000392	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	1.16e-05	0.000391	CbGpPWpGaD
Nepafenac—PTGS2—Disease—P4HB—coronary artery disease	1.14e-05	0.000386	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC22A3—coronary artery disease	1.14e-05	0.000386	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ARNTL—coronary artery disease	1.13e-05	0.00038	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HADH—coronary artery disease	1.13e-05	0.00038	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PPP3R1—coronary artery disease	1.12e-05	0.000379	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—VCAN—coronary artery disease	1.12e-05	0.000377	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—LPL—coronary artery disease	1.11e-05	0.000374	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALDOA—coronary artery disease	1.11e-05	0.000374	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—coronary artery disease	1.1e-05	0.000372	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CYBB—coronary artery disease	1.08e-05	0.000366	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NPPA—coronary artery disease	1.08e-05	0.000366	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—GPX1—coronary artery disease	1.08e-05	0.000365	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—coronary artery disease	1.08e-05	0.000365	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—DCN—coronary artery disease	1.08e-05	0.000363	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PLA2G2A—coronary artery disease	1.07e-05	0.000361	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOA2—coronary artery disease	1.07e-05	0.000361	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GPX2—coronary artery disease	1.07e-05	0.000361	CbGpPWpGaD
Nepafenac—PTGS2—Disease—VCAN—coronary artery disease	1.06e-05	0.000357	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MAP2K3—coronary artery disease	1.06e-05	0.000357	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GPX4—coronary artery disease	1.06e-05	0.000356	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ABCG5—coronary artery disease	1.06e-05	0.000356	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HK1—coronary artery disease	1.06e-05	0.000356	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SULT1A1—coronary artery disease	1.06e-05	0.000356	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CD36—coronary artery disease	1.05e-05	0.000356	CbGpPWpGaD
Nepafenac—PTGS2—Disease—ALDOA—coronary artery disease	1.05e-05	0.000355	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALDH2—coronary artery disease	1.05e-05	0.000353	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HADHA—coronary artery disease	1.04e-05	0.000352	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GSTA1—coronary artery disease	1.03e-05	0.000348	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—coronary artery disease	1.03e-05	0.000348	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CST3—coronary artery disease	1.03e-05	0.000347	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	1.02e-05	0.000344	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LIPC—coronary artery disease	1.02e-05	0.000344	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HBA1—coronary artery disease	1.02e-05	0.000344	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP2C19—coronary artery disease	1.02e-05	0.000344	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PIK3C2A—coronary artery disease	1.02e-05	0.000344	CbGpPWpGaD
Nepafenac—PTGS2—Disease—DCN—coronary artery disease	1.02e-05	0.000344	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LPA—coronary artery disease	1.02e-05	0.000344	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOC3—coronary artery disease	1.01e-05	0.000342	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LDLR—coronary artery disease	1.01e-05	0.00034	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	1.01e-05	0.00034	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GSTT1—coronary artery disease	9.96e-06	0.000336	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SLC9A1—coronary artery disease	9.96e-06	0.000336	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PLCB3—coronary artery disease	9.87e-06	0.000333	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CETP—coronary artery disease	9.84e-06	0.000332	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GCLC—coronary artery disease	9.84e-06	0.000332	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOA5—coronary artery disease	9.77e-06	0.00033	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SDC1—coronary artery disease	9.73e-06	0.000328	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APOC3—coronary artery disease	9.61e-06	0.000324	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—P4HB—coronary artery disease	9.58e-06	0.000323	CbGpPWpGaD
Nepafenac—PTGS2—Disease—LDLR—coronary artery disease	9.55e-06	0.000322	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—AGT—coronary artery disease	9.49e-06	0.00032	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SLC9A1—coronary artery disease	9.44e-06	0.000318	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PLA2G1B—coronary artery disease	9.41e-06	0.000317	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	9.39e-06	0.000317	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—APOE—coronary artery disease	9.3e-06	0.000314	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SDC1—coronary artery disease	9.23e-06	0.000311	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—APOA1—coronary artery disease	9.2e-06	0.00031	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PSMB5—coronary artery disease	9.19e-06	0.00031	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PSMA6—coronary artery disease	9.19e-06	0.00031	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	9.18e-06	0.00031	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CTGF—coronary artery disease	8.98e-06	0.000303	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GOT2—coronary artery disease	8.9e-06	0.0003	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HMGCR—coronary artery disease	8.9e-06	0.0003	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—VCAN—coronary artery disease	8.87e-06	0.000299	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALDOA—coronary artery disease	8.8e-06	0.000297	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PSMB5—coronary artery disease	8.72e-06	0.000294	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PSMA6—coronary artery disease	8.72e-06	0.000294	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—DCN—coronary artery disease	8.54e-06	0.000288	CbGpPWpGaD
Nepafenac—PTGS2—Disease—GOT2—coronary artery disease	8.44e-06	0.000285	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CYBA—coronary artery disease	8.4e-06	0.000283	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CALR—coronary artery disease	8.36e-06	0.000282	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALDH2—coronary artery disease	8.31e-06	0.00028	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PLCB1—coronary artery disease	8.18e-06	0.000276	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PPARG—coronary artery disease	8.1e-06	0.000273	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HBA1—coronary artery disease	8.1e-06	0.000273	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LIPC—coronary artery disease	8.1e-06	0.000273	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP2C19—coronary artery disease	8.1e-06	0.000273	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PIK3C2A—coronary artery disease	8.1e-06	0.000273	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOC3—coronary artery disease	8.05e-06	0.000272	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—coronary artery disease	8.03e-06	0.000271	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LDLR—coronary artery disease	8e-06	0.00027	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—POMC—coronary artery disease	7.99e-06	0.00027	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ABCA1—coronary artery disease	7.93e-06	0.000268	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC9A1—coronary artery disease	7.9e-06	0.000267	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GSTT1—coronary artery disease	7.9e-06	0.000267	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GCLC—coronary artery disease	7.81e-06	0.000264	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CETP—coronary artery disease	7.81e-06	0.000264	CbGpPWpGaD
Nepafenac—PTGS2—Disease—JUNB—coronary artery disease	7.79e-06	0.000263	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HSPA1A—coronary artery disease	7.79e-06	0.000263	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SDC1—coronary artery disease	7.73e-06	0.000261	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GGT1—coronary artery disease	7.68e-06	0.000259	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GOT1—coronary artery disease	7.68e-06	0.000259	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	7.67e-06	0.000259	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PSMA6—coronary artery disease	7.3e-06	0.000246	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PSMB5—coronary artery disease	7.3e-06	0.000246	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ALB—coronary artery disease	7.29e-06	0.000246	CbGpPWpGaD
Nepafenac—PTGS2—Disease—GOT1—coronary artery disease	7.28e-06	0.000246	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CTGF—coronary artery disease	7.13e-06	0.000241	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HMGCR—coronary artery disease	7.07e-06	0.000238	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GOT2—coronary artery disease	7.07e-06	0.000238	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GSTP1—coronary artery disease	6.9e-06	0.000233	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PPARGC1A—coronary artery disease	6.84e-06	0.000231	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HMOX1—coronary artery disease	6.81e-06	0.00023	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PRKCE—coronary artery disease	6.72e-06	0.000227	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CAT—coronary artery disease	6.72e-06	0.000227	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TGFBR2—coronary artery disease	6.54e-06	0.000221	CbGpPWpGaD
Nepafenac—PTGS2—Disease—KITLG—coronary artery disease	6.54e-06	0.000221	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOB—coronary artery disease	6.52e-06	0.00022	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PLCB1—coronary artery disease	6.5e-06	0.000219	CbGpPWpGaD
Nepafenac—PTGS2—Disease—STAT5A—coronary artery disease	6.39e-06	0.000216	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GSTM1—coronary artery disease	6.34e-06	0.000214	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ABCA1—coronary artery disease	6.3e-06	0.000213	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LPL—coronary artery disease	6.23e-06	0.00021	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APOB—coronary artery disease	6.18e-06	0.000209	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GGT1—coronary artery disease	6.1e-06	0.000206	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GOT1—coronary artery disease	6.1e-06	0.000206	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GPX1—coronary artery disease	6.07e-06	0.000205	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FGF1—coronary artery disease	5.94e-06	0.000201	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CD36—coronary artery disease	5.92e-06	0.0002	CbGpPWpGaD
Nepafenac—PTGS2—Disease—LPL—coronary artery disease	5.9e-06	0.000199	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PPP2CA—coronary artery disease	5.84e-06	0.000197	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—MTHFR—coronary artery disease	5.61e-06	0.000189	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PPP2CA—coronary artery disease	5.54e-06	0.000187	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GSTP1—coronary artery disease	5.48e-06	0.000185	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PRKCD—coronary artery disease	5.44e-06	0.000183	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPARGC1A—coronary artery disease	5.43e-06	0.000183	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HMOX1—coronary artery disease	5.4e-06	0.000182	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CAT—coronary artery disease	5.33e-06	0.00018	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—AGT—coronary artery disease	5.33e-06	0.00018	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MTHFR—coronary artery disease	5.31e-06	0.000179	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOE—coronary artery disease	5.22e-06	0.000176	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOB—coronary artery disease	5.18e-06	0.000175	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—APOA1—coronary artery disease	5.16e-06	0.000174	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HIF1A—coronary artery disease	5.07e-06	0.000171	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GSTM1—coronary artery disease	5.03e-06	0.00017	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APOE—coronary artery disease	4.95e-06	0.000167	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LPL—coronary artery disease	4.94e-06	0.000167	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	4.94e-06	0.000167	CbGpPWpGaD
Nepafenac—PTGS2—Disease—APOA1—coronary artery disease	4.89e-06	0.000165	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GPX1—coronary artery disease	4.82e-06	0.000163	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CD36—coronary artery disease	4.7e-06	0.000158	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IL6ST—coronary artery disease	4.65e-06	0.000157	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPP2CA—coronary artery disease	4.64e-06	0.000156	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOS2—coronary artery disease	4.61e-06	0.000156	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PPARG—coronary artery disease	4.55e-06	0.000153	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—POMC—coronary artery disease	4.48e-06	0.000151	CbGpPWpGaD
Nepafenac—PTGS2—Disease—KIT—coronary artery disease	4.46e-06	0.000151	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—MTHFR—coronary artery disease	4.45e-06	0.00015	CbGpPWpGaD
Nepafenac—PTGS2—Disease—GSK3B—coronary artery disease	4.28e-06	0.000145	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CREB1—coronary artery disease	4.25e-06	0.000143	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—AGT—coronary artery disease	4.23e-06	0.000143	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IL6R—coronary artery disease	4.15e-06	0.00014	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOE—coronary artery disease	4.14e-06	0.00014	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—APOA1—coronary artery disease	4.1e-06	0.000138	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALB—coronary artery disease	4.09e-06	0.000138	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	3.92e-06	0.000132	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NOS3—coronary artery disease	3.91e-06	0.000132	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SERPINE1—coronary artery disease	3.88e-06	0.000131	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FGF2—coronary artery disease	3.76e-06	0.000127	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOS3—coronary artery disease	3.71e-06	0.000125	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPARG—coronary artery disease	3.61e-06	0.000122	CbGpPWpGaD
Nepafenac—PTGS2—Disease—JAK2—coronary artery disease	3.6e-06	0.000122	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PTGS2—coronary artery disease	3.58e-06	0.000121	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—POMC—coronary artery disease	3.56e-06	0.00012	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALB—coronary artery disease	3.24e-06	0.000109	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NOS3—coronary artery disease	3.1e-06	0.000105	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TGFB1—coronary artery disease	2.45e-06	8.27e-05	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MAPK1—coronary artery disease	2.4e-06	8.11e-05	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PIK3CA—coronary artery disease	2.2e-06	7.42e-05	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PIK3CA—coronary artery disease	2.09e-06	7.04e-05	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IL6—coronary artery disease	1.85e-06	6.23e-05	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—AKT1—coronary artery disease	1.8e-06	6.06e-05	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PIK3CA—coronary artery disease	1.75e-06	5.89e-05	CbGpPWpGaD
Nepafenac—PTGS2—Disease—AKT1—coronary artery disease	1.7e-06	5.75e-05	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—AKT1—coronary artery disease	1.43e-06	4.81e-05	CbGpPWpGaD
